Leonteq Securities’s BeOne Medicines ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$48.7K Hold
133
– – ﹤0.01% 782
2026
Q2
$37.9K Buy
133
+31
+30% +$9.14K ﹤0.01% 858
2026
Q1
$30.3K Sell
102
-14
-12% -$4.53K ﹤0.01% 938
2025
Q4
$35.2K Sell
116
-13
-10% -$4.26K ﹤0.01% 1009
2025
Q3
$44K Sell
129
-40
-24% -$12.1K ﹤0.01% 905
2025
Q2
$40.9K Sell
169
-7
-4% -$1.72K ﹤0.01% 882
2025
Q1
$47.9K Buy
176
+35
+25% +$8.18K ﹤0.01% 838
2024
Q4
$26K Buy
+141
New +$28.8K ﹤0.01% 932
2023
Q2
– Sell
-128
Closed -$27.6K – 1324
2023
Q1
$27.6K Sell
128
-39
-23% -$9.36K ﹤0.01% 898
2022
Q4
$36.7K Hold
167
– – ﹤0.01% 881
2022
Q3
$22.5K Hold
167
– – ﹤0.01% 938
2022
Q2
$27K Hold
167
– – ﹤0.01% 942
2022
Q1
$31.5K Hold
167
– – ﹤0.01% 946
2021
Q4
$45.2K Hold
167
– – ﹤0.01% 922
2021
Q3
$60.6K Sell
167
-224
-57% -$73.2K ﹤0.01% 815
2021
Q2
$134K Sell
391
-1,120
-74% -$371K 0.01% 657
2021
Q1
$526K Sell
1,511
-1,842
-55% -$610K 0.03% 377
2020
Q4
$866K Buy
+3,353
New +$923K 0.05% 308

Other funds holding ONC

Leonteq Securities's ONC Position: Q3 2026 in Review

Leonteq Securities held its BeOne Medicines (ONC) position steady in Q3 2026 at 133 shares worth $48.7K. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Leonteq Securities first reported a position in ONC in Q4 2020 and has held it in 18 quarters since. The position peaked at $866K in Q4 2020. 264 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Leonteq Securities held 133 shares of BeOne Medicines worth $48.7K as of Q3 2026.
  • Leonteq Securities left its BeOne Medicines share count unchanged in Q3 2026.
  • BeOne Medicines made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #782 holding.
  • Leonteq Securities first reported a position in BeOne Medicines in Q4 2020 and has held it in 18 quarters since.
  • Leonteq Securities's BeOne Medicines position peaked at $866K in Q4 2020.
  • 264 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.